COMPANY
MAA Laboratories Inc.
Our internal pipeline focuses on reformulating established active pharmaceutical ingredients (APIs) to improve bioavailability, reduce dose-related toxicity, and enable patient-friendly dosage forms—without the need for extensive clinical development. From company website Source · Oct 13, 2026